Arno Therapeutics, Inc
CIK 0001195116
Revenue (TTM)
—
Q3 Nov 2016
Net Income (TTM)
−$10.38M
−248.1% YoY
Q3 Nov 2016
EPS Diluted (TTM)
−$0.05
−280.6% YoY
Q3 Nov 2016
Gross Margin
—
Q3 Nov 2016
Operating Margin
—
Q3 Nov 2016
Net Margin
—
Q3 Nov 2016
Free Cash Flow (TTM)
−$12.52M
Q3 Nov 2016
Cash
$2.12M
Q3 Nov 2016
Total Debt
$0
Q3 Nov 2016
Shares Outstanding
49.35M sh
Q3 Nov 2016
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.